UK Government Called To Action To Further Boost IP Enforcement 19/07/2016 by Intellectual Property Watch 1 Comment The United Kingdom-based Anti-Counterfeiting Group (ACG) industry group launched a “manifesto” earlier this month, calling on the government to establish a more effective and comprehensive response to intellectual property crime.
EU Anti-Counterfeiting Rapid Intelligence System: One Database For All Data On IPR Infringement 19/07/2016 by Intellectual Property Watch Leave a Comment The European Union Intellectual Property Office (EUIPO) and the European Commission Trade Directorate recently launched a new intellectual property enforcement tool that aims to pool together all data relating to IP rights infringement experienced by EU companies into one database to help build prevention strategies. This is one of many new EU initiatives to counter growing IPR infringement and counterfeits.
CISAC: 90 Years In The Service Of Authors And Composers 19/07/2016 by Intellectual Property Watch Leave a Comment The International Confederation of Societies of Authors and Composers (CISAC), the world’s leading network of authors’ societies, has published a book looking back at its 90 years in existence. The CISAC Story – 90 Years in the Service of Authors and Creators Worldwide, was distributed in three languages at the Confederation’s General Assembly last month in Paris.
UNCTAD Conference Opens With High-Level Calls For Action On Trade And Development 18/07/2016 by Fredrick Nzwili for Intellectual Property Watch 2 Comments NAIROBI, Kenya (IP-Watch) – The United Nations Conference on Trade and Development (UNCTAD) 14th Session opened here yesterday, with leaders calling for deeper and broader cooperation between trade and development.
Industry Report Tracks Innovation’s Value To AIDS Treatment In Developing Countries 18/07/2016 by William New, Intellectual Property Watch 2 Comments A new report launched in time for this week’s AIDS conference in South Africa analyzes factors relating to access to HIV/AIDS treatments over the past 15 years. The analysis includes a look at government policies used during that time, the contribution of generic and research-based industries, and the importance of voluntary licensing.
TTIP Negotiators Need Many More Nights To Negotiate – And Are Planning Just That 15/07/2016 by Monika Ermert for Intellectual Property Watch 1 Comment Top negotiators of the European Union and United States today underlined after the 14th round of negotiations for the Transatlantic Trade and Investment Partnership (TTIP) that they are still on track for finalising the deal during the outgoing Obama administration. At the same time, they acknowledged that after three years of negotiations some chapters have never been discussed.
Orphan Drugs Finding Home In Markets: Could Be 20% Of All Sales By 2020 15/07/2016 by Intellectual Property Watch 2 Comments Worldwide sales for orphan drugs are forecast to reach $178 billion by 2020, according to a recent industry report. Moreover, the orphan drug market is expected to grow almost 12 percent per year, a level the broader pharmaceutical market “could only dream about” with its expected annual growth of 5.9 percent, according to Lisa Urquhart, editor of EvaluatePharma Vantage.
For UNCTAD Ministerial, NGOs Call For Development Focus, Not Trade Rules Enforcement 14/07/2016 by Catherine Saez, Intellectual Property Watch 1 Comment Days before a major meeting of the governing body of the United Nations Conference on Trade and Development (UNCTAD), over 100 non-governmental organisations worldwide are calling for the organisation to maintain its development role and not help implement international and regional trade rules.
WIPO Names Vivendi Executive Sylvie Forbin Of France New DDG For Copyright 14/07/2016 by William New, Intellectual Property Watch 3 Comments The World Intellectual Property Organization director general has named Sylvie Forbin of France, a veteran diplomat and copyright industry representative, as the next head of the WIPO Copyright and Creative Industries Sector. Forbin was chosen from more than 300 applicants, according to WIPO.
Gilead’s Use Of Patents For $10B Tax Dodge Could Ignite Move For Policy Change 13/07/2016 by William New, Intellectual Property Watch Leave a Comment Gilead is the US company whose use of patents to charge $1000 per pill for a hepatitis C medicine in the United States helped make high drug prices a developed country household issue and fodder for elected officials seeking change. Now the company has come under further fire after being found to have moved some US$10 billion overseas to avoid US taxes – even after having received US taxpayer support for its activities – which it orchestrated by moving its patent rights overseas. A new report detailing the company’s tax dodge includes a proposal for a way to clamp down on this type of patent activity.